Glyx 13 Powder

Glyx 13 powder (generic name: Rapastinel) is an amidated tetrapeptide (Threonine-Proline-Proline-Threonine amide) derived from a monoclonal antibody. Distinguished by its unique mechanism of action, rapid and long-lasting antidepressant activity, and favorable safety profile, it is a pivotal candidate for overcoming the limitations of traditional antidepressants. Acting as a partial agonist at the glycine site of the NMDA receptor, and characterized by its core attributes-namely, rapid neuroplasticity remodeling, sustained antidepressant effects, cognitive enhancement, and high safety-it represents a significant innovation in the neuropsychiatric field. It's proven that using "NMDA receptor partial agonism" to treat depression actually works. Right now, it's used a lot in neuroscience research-its way of working and how safe it is keep being important references for developing treatments for things like depression and cognitive disorders.If you want to learn more, contact Xi'an Sonwu Biotech Co., Ltd.

Xi'an Sonwu Biotech Co., Ltd is a peptide raw material supplier with peptide technology at its core and an international market orientation. Sonwu is dedicated to the R&D, manufacturing, and worldwide distribution of bioactive peptide and polypeptide ingredients. Sonwu's products are widely applied in multiple fields, including muscle building, beauty and anti-aging, hair health, weight management, nootropics, and pharmaceutical raw materials.

Sonwu's products serve a global clientele, supporting both research and development and industrialization projects. Based on this, Sonwu has received a lot of feedback on Sonwu's products. Therefore, if you need glyx 13, please contact Xi'an Sonwu.

Xi'an Sonwu not only provides large-scale production services but can also provide sample packages to customers first.

Xi'an Sonwu not only supplies high - quality glyx 13, but can also customize products according to customer needs. In addition, Sonwu can provide customized packaging services, including repackaging products according to customer requirements.

1. Customized bottles(size, color, material, style)

2. Customized packaging(vacuum foil packaging, box, drum)

3. Customized label(paint film, matte film, optical mask)

Glyx 13 powder mainly acts on NMDA receptors in the brain and nervous system, and its mechanism of action is quite different from that of other common NMDA-regulating drugs.

NMDA receptors are vital protein channels that control nerve signal transmission and brain development. To activate these receptors, glutamate and glycine must bind to them simultaneously.

Glyx 13 acts as a mild regulator that binds to the glycine-binding site on these receptors. It selectively binds to a unique structural domain on the receptor, thereby exerting a bidirectional modulatory effect. Put simply, it specifically targets NR2B-type NMDA receptors. When nerve impulses travel slowly and weakly, it calms receptor activity, protecting nerve cells from overstimulation. On the other hand, when neurons send frequent, strong signals, it allows more calcium to flow into cells and triggers downstream nerve signaling cascades.

This balanced adjustment helps strengthen stable neural connections in the hippocampus and frontal brain areas, while reducing weak, unhealthy synaptic responses. As a result, damaged brain connections in people with depression get repaired much faster. It also boosts natural BDNF production inside the brain and supports the growth of healthy, fully developed nerve branches. This "neural plasticity remodeling" effect persists for several weeks-far exceeding the drug's metabolic half-life-thereby laying the foundation for its long-lasting therapeutic efficacy.

1. Rapid Antidepressant Action: Breaking Through Traditional Limitations

Glyx 13 significantly alleviates depressive symptoms, with effects lasting for over seven days. It holds critical significance for patients with treatment-resistant depression by rapidly improving mood and eliminating suicidal ideation.

2. Dual Efficacy: Cognitive Enhancement

In addition to its antidepressant properties, it acts as a potent cognitive enhancer, improving learning, memory, and attention. It has been shown to boost performance in cognitive tasks-such as water mazes and trace eyeblink conditioning-in both young and aging individuals. Furthermore, it can reverse cognitive impairments induced by chronic stress, thereby addressing the cognitive deficits frequently associated with depression.

3. High Safety Profile: Free from Severe Side Effects

Unlike other NMDA modulators such as ketamine, it does not induce schizophrenia-like side effects, nor does it carry risks of addiction, sedation, or cognitive impairment. Adverse reactions are predominantly mild-including headaches, dizziness, and nausea-with an incidence rate comparable to placebo. It causes no severe cardiovascular, hepatic, or renal dysfunction, making it suitable for long-term adjunctive therapy.

4. No Risk of Drug Tolerance or Interactions

Repeated administration has shown no evidence of tolerance; the antidepressant efficacy does not diminish with continued use. Moreover, glyx 13 utilizes an independent metabolic pathway and exhibits no significant interactions with commonly prescribed antidepressant or anxiolytic medications.

1. Primary Indication: Treatment-Resistant Depression

The core development focus of glyx 13 is as an adjunctive therapy for treatment-resistant major depressive disorder.

2. Potential Expanded Indications

Post-Traumatic Stress Disorder (PTSD): It can repair damaged nerve connections in the front part of the brain, fix emotional control issues caused by traumatic experiences, and greatly ease troubling fear memories as well as anxious actions.

Cognitive Impairment-Related Disorders: Exerts neuroprotective and cognitive-enhancing effects to address cognitive decline associated with Alzheimer's disease and vascular dementia, or attentional deficits associated with Attention Deficit Hyperactivity Disorder (ADHD).

Neuropathic Pain: Acts by modulating central NMDA receptors to inhibit pain signal transmission, thereby providing both analgesic and mood-improving benefits.

1. Xi'an Sonwu Biotech Co . Ltd has established a complete technology platform covering peptide molecular design, custom synthesis, precision purification, structural identification, and quality control. Strictly adhering to international quality management standards, the company ensures that its peptide raw materials meet the high-end raw material requirements of overseas customers in terms of purity, stability, and batch consistency.

2. Looking to the future, Sonwu will continue to deepen peptide technology innovation, expand Sonwu's global cooperation network, and strive to become a trusted long-term peptide raw material solution partner for international customers.

Besides guaranteeing the product, the most important thing is that customers receive the goods smoothly. So, Xi'an Sonwu offers a range of couriers to meet different needs.

Glyx 13 powder is associated with a low incidence of side effects, which are predominantly mild and transient:

1. Common Mild Side Effects

These occur at a low incidence and show no significant difference compared to placebo: headache, dizziness, fatigue, nausea, dry mouth, and mild redness or swelling at the injection site. These symptoms typically resolve spontaneously without the need for specific intervention.

2. Rare Adverse Reactions

Infrequent occurrences of mild blood pressure fluctuations and sleep disturbances (insomnia or drowsiness) have been observed. The incidence is extremely low, and symptoms resolve rapidly following discontinuation of the medication.

3. Absolute Contraindications and Precautions

Contraindicated in individuals with a known allergy to peptide-based medications;

Safety has not been established in pregnant or lactating women, nor in children; therefore, use is currently not recommended in these populations.

Caution is advised in patients with severe hepatic or renal impairment, as there are currently no established guidelines for dose adjustment in this population.

If you want to find a glyx 13 supplier, contact Xi'an Sonwu. Click the email, and then you get high-quality products.

Email: sales02@sonwu.com

Hot Tags: glyx 13 powder, China glyx 13 powder manufacturers, suppliers, factory, pharmaceutical peptides, Piperlongumine Powder, TB500 Powder